Syrma SGS Tech.
Syrma SGS Tech. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
4 of 5 strong
The short version
The company aims to sustain a 30%-35% revenue growth rate over the next 3 to 5 years, specifically for FY27-28 and FY28-29. Syrma SGS Technology Limited expects to exceed its guided growth of 35%+ revenue for the current fiscal year and maintain a similar growth rate for at least the next 2-3 years ('27-'28, '28-'29).
From Syrma SGS Tech.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- The company aims to sustain a 30%-35% revenue growth rate over the next 3 to 5 years, specifically for FY27-28 and FY28-29.
- New global clients onboarded have potential to accelerate growth beyond this range, though large-scale contributions are expected from the third year of onboarding.
- Exports grew by 40% last year and nearly 60% in Q1 FY27; expected to grow 30%-40% for the current year, reaching Rs. 1,500-1,600 crore.
- Automotive, industrial, and MedTech sectors are key drivers for export growth; automotive, especially EV-related, is a cornerstone domestically.
- Consumer business expected to remain around 30% of total revenue with quarterly aberrations.
- Defense segment, recently acquired, is in early stages but anticipated to grow at 30%-35%.
- New customer additions (18 onboarded recently) with full ramp-up expected to add Rs. 1,000 crore+ in future revenue.
- ODM business, currently 17% of sales, targets 25% over several years, requiring 50%-60% growth in ODM sales.
Profitability & Margins
See what Syrma SGS Tech. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current year CAPEX (ex PCB) expected around Rs. 100-150 crore; Rs. 40 crore incurred in Q1.
- Capacity expansions ongoing in Bangalore (new facility) and Pune plants.
- Additional capacity being set up for MedTech business in Jodhpur, including medical-grade plastics and SMT lines; expected growth opportunity from FY '27-'28.
- PCB manufacturing project progressing on schedule, with Rs. 50 crore invested in the quarter and total initial phase CAPEX around Rs. 400 crore.
- PCB project phase 1 expected to start commercial production by April 2027; phase 2 and 3 planned for late '27/early '28.
- Funding for PCB project through internal accruals, government CAPEX incentives (50%), and around 50-60% debt.
- Strategic inventory investments continuing to support customer ramp-ups and mitigate supply chain challenges.
- Investment in joint venture with Japanese MNC Kaga, initial Rs. 24-25 crore.
Top-ranked in Industrial Manufacturing
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Syrma SGS Tech. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of June end, Syrma SGS Technology Limited has an overall order book visibility of approximately Rs. 6,770 crores.
- Out of this, around Rs. 5,400 crores (approximately 80%) is expected to be executed in the next 12 months.
- The remaining balance is scheduled beyond 12 months.
- The average execution period for existing orders is around 10 to 10.5 months.
- The company’s quarterly order intake shows an increasing trend, with a one-year and one-quarter intake of about Rs. 1,781 crores.
- The company is guiding for continued strong order intake to support a revenue growth target of 35%+ for the full year.
- New customer additions (18 onboarded in the latest quarter) are expected to contribute to order book growth in coming years rather than immediately.
Syrma SGS Tech. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.5K Cr, net profit ₹119 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Syrma SGS Technology Ltd's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Industrial Manufacturing this season
- Aaron Industries Ltd (Q1 FY27)
Profit After Tax showed strong YoY growth (141.94% in Q1FY27), indicating robust profitability momentum. Key concall takeaways from Aaron Industries Ltd's Q1…
- The Anup Engineering Ltd (Q1 FY27)
New order book at best-ever levels (INR 985 crores), indicating robust future demand. Key concall takeaways from The Anup Engineering Ltd's Q1 FY27 earnings…
- Hirect Ltd (Q1 FY27)
Long-term ambition to become a ₹1 billion revenue company within 4-5 years supported by expansion into propulsion systems, trainsets, and international…
- MV Electrosystems Ltd (Q1 FY27)
Plan to reach a run rate of 40 propulsion systems per month, translating roughly to ₹700+ crores annual revenue in subsequent years. Key concall takeaways from…
Frequently Asked Questions
What were Syrma SGS Tech. Q1 FY27 results?
The company aims to sustain a 30%-35% revenue growth rate over the next 3 to 5 years, specifically for FY27-28 and FY28-29. Syrma SGS Technology Limited expects to exceed its guided growth of 35%+ revenue for the current fiscal year and maintain a similar growth rate for at least the next 2-3 years ('27-'28, '28-'29).
What is Syrma SGS Tech. share price analysis?
Syrma SGS Tech. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 74.7 with a market cap of ₹27,754 Cr. Investors should review the full earnings analysis for detailed insights.
Is Syrma SGS Tech. planning capital expenditure?
Current year CAPEX (ex PCB) expected around Rs.
Keep Syrma SGS Tech. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.